When confronting globally prevalent infectious diseases, time is the ultimate clinical variable. While chronic pathogens like Mycobacterium tuberculosis slowly degrade host tissues over months, acute diarrheal pathogens like Vibrio cholerae can cause lethal dehydration within ...Learn More

For decades, translational medicine has faced a frustrating bottleneck: why do over 90% of oncology and neurology drug candidates that show dazzling success in preclinical lab testing ultimately fail when injected into human patients? The answer lies in the structural limitations ...Learn More

The therapeutic landscape is undergoing a conceptual shift as researchers move beyond single-target drugs to embrace the systemic complexity of Live Biotherapeutic Products (LBPs). No longer dismissed as mere digestive aids, next-generation probiotics and engineered live microbes ...Learn More

Multiple Sclerosis (MS) remains a primary focus of neuro-immunology due to its complex pathology and the diverse clinical manifestations observed in patients. As a chronic autoimmune disease of the central nervous system (CNS), MS involves a sophisticated interplay of ...Learn More

Antibody-Drug Conjugates (ADCs) have revolutionized oncology, earning their reputation as biological "Trojan horses." By tethering a highly potent cytotoxic payload to a target-specific monoclonal antibody, ADCs promise to deliver chemotherapy directly to malignant cells while ...Learn More